About Us

Company Profile

The company focuses on R&D and innovation, and has formed core technical advantages in large-scale medicinal protein enrichment, purification and quality control, and a number of technologies have been authorized by national invention patents. Jiangxi Haoran Bio-Pharmaceutical Co., Ltd. is located in Nanchang High-tech Zone. Since its establishment in 2008, the company has adhered to the principle of scientific and technological innovation, pioneering and enterprising, pragmatic and heavy-duty, and taking the road of high-quality development. After more than ten years of development, the company has grown into a comprehensive pharmaceutical enterprise integrating R&D, production and marketing of pharmaceutical intermediates, APIs and preparations.

about1
about2

The company focuses on R&D and innovation, and has formed core technical advantages in large-scale medicinal protein enrichment, purification and quality control, and a number of technologies have been authorized by national invention patents. The developed products mainly include urokinase, ulinastatin, chorionic gonadotropin, urinary gonadotropin and urinary follicle stimulating hormone, etc. The core products are in the leading position in the industry segment. The product market covers Europe, Japan, South Korea and India and other countries and regions.

Honors

certificate1
certificate2
certificate3
certificate4
certificate6
certificate7
certificate5
certificate8
certificate9
certificate10
certificate11

Company Development History

  • 2008
    Jiangxi Haoran Bio-Pharma Co.,Ltd established.
  • 2011
    Recognized as a National High-tech Enterprise.Passed PMDA inspection.
  • 2014
    Haoran's new factory was completed and relocated to the new factory. Obtained manufacture license.
  • 2015
    Awarded the Jiangxi Provincial Enterprise Technology Center.
  • 2016
    Obtained production drug license of HCG API, and production workshop passed the GMP certification.
  • 2018
    Obtained GMP certificate of kallidinogenase API.
  • 2019
    Production plant of freeze-dried powder injection built. Obtained the production license of freeze-dried powder injection.
  • 2020
    Built the production base of animal resource biological drugs.
  • 2022
    Formulation production line was passed GMP inspection.

The company's factory covers an area of ??70,000 square meters, has high-end pharmaceutical equipment, brings together a first-class professional team, and establishes a scientific and sound management system. laid a good foundation.